TCL Archive FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March. January 21, 2005
TCL Archive Undeterred By Randomized Trial Results, AUA Calls For Baseline PSA At Age 40. May 1, 2009